EPHESUS Post-MI Eplerenone Response Score
Clinical eligibility and exploratory index
Enter post-MI clinical and laboratory values. This index is illustrative and is not a validated treatment-response prediction model.
Clinical context
EPHESUS evaluated eplerenone in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure, with diabetes permitting enrollment without demonstrable heart-failure symptoms when LVEF criteria were met.
Core criteria represented in this tool
| Criterion | Rule used |
|---|---|
| Timing after MI | 3–14 days |
| LVEF | ≤40% |
| Clinical condition | Heart-failure signs/symptoms OR diabetes |
| Trial laboratory exclusions | Creatinine >2.5 mg/dL or potassium >5.0 mEq/L were exclusion criteria |
About the exploratory index
The original source code assigns illustrative points for LVEF category, diabetes, heart-failure signs, age >65 years, creatinine ≥2.0 mg/dL, and potassium ≥5.0 mEq/L. These weights are not a validated score, and the total must not be interpreted as an individual treatment-response probability or used to decide treatment.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.